LEADER 01407nam--2200433---450- 001 990001477530203316 005 20060210133831.0 010 $a0-13-048434-2 035 $a000147753 035 $aUSA01000147753 035 $a(ALEPH)000147753USA01 035 $a000147753 100 $a20040304d2002----km-y0enga50------ba 101 0 $aeng 102 $aUS 105 $ay|||z|||001yy 200 1 $aAdaptive filter theory$fSimon Haykin 205 $a4. ed 210 $aUpper Saddle River$cPrentice Hall$dcopyr. 2002 215 $aXVI, 920 p.$d26 cm 225 2 $aPrentice Hall information and system sciences series 410 0$12001$aPrentice Hall information and system sciences series 606 0 $aFiltri elettrici 676 $a621.3815324 HAY 700 1$aHAYKIN,$bSimon$08857 801 0$aIT$bsalbc$cISBD 912 $a990001477530203316 951 $a621.3815324 HAY (A)$b18442 Ing.$c621.3815324$d00133585 951 $a621.3815324 HAY (C)$b19431 Ing.$c621.3815324$d00175999 959 $aBK 969 $aTEC 979 $aMARIA$b10$c20040304$lUSA01$h1250 979 $aPATRY$b90$c20040406$lUSA01$h1743 979 $aALESSANDRA$b90$c20040809$lUSA01$h1221 979 $aALESSANDRA$b90$c20040809$lUSA01$h1233 979 $aANNAMARIA$b90$c20060210$lUSA01$h1337 979 $aANNAMARIA$b90$c20060210$lUSA01$h1338 996 $aAdaptive filter theory$9112739 997 $aUNISA LEADER 01335nam 2200409 450 001 9910467383503321 010 $a90-272-6329-9 035 $a(CKB)4100000007188603 035 $a(MiAaPQ)EBC5622407 035 $a(EXLCZ)994100000007188603 100 $a20190119d2018 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aTopics in theoretical Asian linguistics $estudies in honor of John B. Whitman /$fedited by Kunio Nishiyama, Hideki Kishimoto, Edith Aldridge 210 1$aAmsterdam ;$aPhiladelphia :$cJohn Benjamins Publishing Company,$d[2018] 210 4$dİ2018 215 $a1 online resource (412 pages) 225 1 $aLinguistik aktuell ;$vVolume 250 =$aLinguistics today (LA) 311 $a90-272-0172-2 320 $aIncludes bibliographical references and index. 410 0$aLinguistik aktuell ;$vVolume 250.$x0166-0829 607 $aAsia$xLanguages 608 $aElectronic books. 676 $a495 702 $aNishiyama$b Kunio 702 $aKishimoto$b Hideki 702 $aAldridge$b Edith 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910467383503321 996 $aTopics in theoretical Asian linguistics$92046144 997 $aUNINA LEADER 01563nas 2200505 a 450 001 996204741003316 005 20231101153826.0 011 $a1879-2677 035 $a(OCoLC)39224664 035 $a(CKB)954926241476 035 $a(CONSER) 2001242159 035 $a(DE-599)ZDB1499759-9 035 $a(EXLCZ)99954926241476 100 $a19980604a19899999 sy a 101 0 $aeng 135 $aurcn|||||| 200 10$aSignal processing$iImage communication$b[e-journal] 210 $aNew York, NY $cElsevier Science Pub. Co 300 $aRefereed/Peer-reviewed 311 $a0923-5965 517 3 $aImage communication 517 $aSignal Processing: Image Communication 531 $aSIGNAL PROCESS-IMAGE 531 $aSIGNAL PROCESSING 531 $aSIGNAL PROCESS IMAGE 531 $aSIGNAL PROCESS IMAGE COMMUN 531 $aSIG PROC IM 531 0 $aSignal process., Image commun. 531 0 $aSignal process., Image commun. 531 $aIMAGE 531 $aSIGNAL PROCESS.-IMAGE COMMUN 606 $aImaging systems$vPeriodicals 606 $aImage processing$vPeriodicals 606 $aImage processing$2fast$3(OCoLC)fst00967501 606 $aImaging systems$2fast$3(OCoLC)fst00967605 608 $aPeriodicals.$2fast 615 0$aImaging systems 615 0$aImage processing 615 7$aImage processing. 615 7$aImaging systems. 712 02$aEuropean Association for Signal Processing. 906 $aJOURNAL 912 $a996204741003316 996 $aSignal processing$9103132 997 $aUNISA LEADER 06194nam 2200661 450 001 9910820490403321 005 20230725045551.0 010 $a1-4511-2478-3 010 $a1-4698-8987-0 010 $a1-4698-7548-9 035 $a(CKB)3360000000010559 035 $a(EBL)2031957 035 $a(OCoLC)759168484 035 $a(SSID)ssj0000446032 035 $a(PQKBManifestationID)12174415 035 $a(PQKBTitleCode)TC0000446032 035 $a(PQKBWorkID)10491736 035 $a(PQKB)10460841 035 $a(MiAaPQ)EBC3418293 035 $a(MiAaPQ)EBC2031957 035 $a(Au-PeEL)EBL3418293 035 $a(CaPaEBR)ebr10825369 035 $a(OCoLC)923526062 035 $a(EXLCZ)993360000000010559 100 $a20100609h20112011 uy| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aNeonatal and pediatric pharmacology $etherapeutic principles in practice /$f[edited by] Sumner J. Yaffe, Jacob V. Aranda 205 $aFourth edition. 210 1$aPhiladelphia :$cWolters Kluwer/Lippincott Williams & Wilkins Health,$d[2011] 210 4$dİ2011 215 $a1 online resource (1066 p.) 300 $aDescription based upon print version of record. 311 $a0-7817-9538-9 320 $aIncludes bibliographical references and index. 327 $a""Neonatal and Pediatric Pharmacology""; ""Contributors""; ""Foreword to the Fourth Edition""; ""Preface to the Third Edition""; ""Preface to the Fourth Edition""; ""Introduction and Historical Perspectives""; ""Clinical Pharmacokinetics in Infants and Children""; ""Drug Action and Therapy in the Infant and Child""; ""Drug Metabolism and Disposition in Infants and Children""; ""Pharmacogenetics, Pharmacogenomics, and Pharmacoproteomics""; ""Adherence with Pediatric Medication Regimens""; ""Clinical Trials Involving Children:""; ""Ethics of Drug Research in Pediatric Populations"" 327 $a""Therapeutic Drug Monitoring""""Drug Formulations""; ""Developmental Toxicology""; ""Biotransformation of Medications by Human Placenta""; ""Maternal Drug Intake and the Newborn""; ""Principles of Neonatal Pharmacology""; ""Perinatal Origins of Adult Defects in Drug Metabolism""; ""Renal Function and Excretion of Drugs in the Newborn""; ""The Excretion of Drugs and Chemicals in Human Milk""; ""Drugs for Hyperbilirubinemia""; ""Drugs and Lung Development""; ""Pharmacologic Treatment of Neonatal Apnea""; ""Drugs and Perinatal Brain Injury"" 327 $a""Antiretroviral Pharmacology in Pregnant Women and Newborns""""Therapeutic Applications in Pediatric Intensive Care""; ""Drug Therapy in the Pediatric Emergency Department*""; ""Drug Therapy in the Adolescent""; ""Topical Medications""; ""Ophthalmologic Drugs in Infants and Children""; ""Sulfonamides""; ""Penicillins, Cephalosporins, and Other""; ""-Lactams""; ""Aminoglycosides and Glycopeptides""; ""Fluoroquinolones""; ""Macrolides, Chloramphenicol, and Tetracyclines""; ""Anthelminthic Drugs in Children""; ""Antituberculosis Drugs""; ""Antifungal Agents"" 327 $a""Antiviral Drugs: Treatment of the Fetus and Newborn""""Anticonvulsants""; ""Psychopharmacology in Children and Adolescents""; ""Antihistamine Drugs""; ""Antiasthmatics""; ""Antipyretics""; ""Cardiovascular Drugs""; ""Diuretics""; ""Clinical Pharmacology of Antineoplastic Drugs""; ""Immunosuppressive and Immunomodulatory Drugs""; ""Analgesic Agents""; ""Local Anesthetic Solutions for Regional Anesthesia in Infants, Children, and Adolescents""; ""Nonsteroidal Anti-Inflammatory Drugs""; ""Antihypertensive Agents""; ""Gastrointestinal Drugs""; ""Glucocorticoids"" 327 $a""Insulin and Diabetes Mellitus""""Thyroid Hormones""; ""Growth Hormone""; ""Hematologic Agents""; ""Nutrient Supplements""; ""Childhood Vaccines""; ""Epidemiology of Adverse Drug Effects""; ""Mechanisms of Adverse Drug Reactions in Children""; ""Medication Errors""; ""Pediatric Poisonings and Antidotes""; ""Use of Herbal Products in Children: Risks and Unproven Benefits""; ""Pharmacologic Management of Neonatal Abstinence Syndrome""; ""Drug Interactions in Newborns and Children""; ""Drug Formulary for the Newborn""; ""Pediatric Drug Formulary""; ""Index"" 330 $a"Neonatal and Pediatric Pharmacology offers guidelines for safe, effective, and rational drug therapy in newborns, children and adolescents. The book provides relevant and useful data on the molecular, physiologic, biochemical, and pharmacologic mechanisms of drug action and therapy in this population. The authors identify areas of innovative basic and translational research necessary for the continuing evaluation and development of drugs for the fetus, newborns, children and adolescents. Neonatal and Pediatric Pharmacology is is a valuable reference for all health care professionals who treat the fetus, newborns, children, and adolescents, including neonatologists, nurses, pediatricians, general practitioners, students, obstetricians, perinatologists, surgeons and allied health professionals. It will be useful anytime during the day and especially in the middle of the night when knowledge of appropriate indications, safe and effective use, dosage, and therapeutic regimen for a certain drug or molecular entity is immediately needed. The book is also directed to those involved in basic, clinical, and other academic pharmacological research, the pharmaceutical industry, and regulatory agencies dealing with drug and therapeutic developments for this population. Those teaching pharmacology and therapeutics will find this compilation of information extremely useful in preparing teaching materials"--Provided by publisher. 606 $aPediatric pharmacology 606 $aChildren$xDiseases$xChemotherapy 615 0$aPediatric pharmacology. 615 0$aChildren$xDiseases$xChemotherapy. 676 $a615/.1083 701 $aAranda$b Jacob V$01645751 702 $aYaffe$b Sumner J.$f1923-2011, 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910820490403321 996 $aNeonatal and pediatric pharmacology$93992423 997 $aUNINA LEADER 03314nam 22005775 450 001 9910739409103321 005 20251202142627.0 010 $a3-030-15948-5 024 7 $a10.1007/978-3-030-15948-1 035 $a(CKB)4100000008048170 035 $a(MiAaPQ)EBC5771223 035 $a(DE-He213)978-3-030-15948-1 035 $a(PPN)235669091 035 $a(EXLCZ)994100000008048170 100 $a20190425d2019 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 14$aThe Reality of Time Flow $eLocal Becoming in Modern Physics /$fby Richard T. W. Arthur 205 $a1st ed. 2019. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2019. 215 $a1 online resource (294 pages) 225 1 $aThe Frontiers Collection,$x2197-6619 311 08$a3-030-15946-9 327 $aIntroduction -- The problem of time in classical philosophy -- Modern objections to time?s passage -- Classical physics and temporal becoming -- Special relativity and the lapse of time -- Relativity and the present -- Time in general relativity -- Becoming in quantum theory -- Conclusion. . 330 $aIt is commonly held that there is no place for the 'now? in physics, and also that the passing of time is something subjective, having to do with the way reality is experienced but not with the way reality is. Indeed, the majority of modern theoretical physicists and philosophers of physics contend that the passing of time is incompatible with modern physical theory, and excluded in a fundamental description of physical reality. This book provides a forceful rebuttal of such claims. In successive chapters the author explains the historical precedents of the modern opposition to time flow, giving careful expositions of matters relevant to becoming in classical physics, the special and general theories of relativity, and quantum theory, without presupposing prior expertise in these subjects. Analysing the arguments of thinkers ranging from Aristotle, Russell, and Bergson to the proponents of quantum gravity, he contends that the passage of time, understood as a local becoming of events out of those in their past at varying rates, is not only compatible with the theories of modern physics, but implicit in them. . 410 0$aThe Frontiers Collection,$x2197-6619 606 $aPhysics$xPhilosophy 606 $aScience$xPhilosophy 606 $aCosmology 606 $aMathematical physics 606 $aPhilosophical Foundations of Physics and Astronomy 606 $aPhilosophy of Science 606 $aCosmology 606 $aTheoretical, Mathematical and Computational Physics 615 0$aPhysics$xPhilosophy. 615 0$aScience$xPhilosophy. 615 0$aCosmology. 615 0$aMathematical physics. 615 14$aPhilosophical Foundations of Physics and Astronomy. 615 24$aPhilosophy of Science. 615 24$aCosmology. 615 24$aTheoretical, Mathematical and Computational Physics. 676 $a530.11 700 $aArthur$b Richard T. W$4aut$4http://id.loc.gov/vocabulary/relators/aut$0838594 906 $aBOOK 912 $a9910739409103321 996 $aThe Reality of Time Flow$93552836 997 $aUNINA